Table 6.
Review/Meta-analysis | Effects on Adherence | Effects on Blood Pressure |
---|---|---|
Glynn et al,65 2010 | • Not assessed | • WMD SBP: −2.5 mm Hg, 95% CI −3.7 to −1.3 • WMD DBP: −1.8 mm Hg, 95% CI −2.4 to −1.2 |
Bray et al,70 2010 | • Not assessed | • WMD SBP: −3.8 mm Hg, 95% CI −5.6 to −2.0 • WMD DBP: −1.5 mm Hg, 95% CI −2.0 to −0.9 |
van Dalem et al,53 2012 |
• Contradictory results (2 studies) |
• Mean DBP: “significant decrease” (2 studies; data not reported) |
Uhlig et al,71 2013 | • “A few studies” found effect (data not reported) |
Self-monitoring only • WMD SBP, 6 mo: −3.9 mm Hg, P<.001 • WMD DBP, 6 mo: −2.4 mm Hg, P<.001 • WMD SBP, 12 mo: −1.5 mm Hg, P>.05 • WMD DBP, 12 mo: −0.8 mm Hg, P>.05 Self-monitoring + additional support • Net difference SBP, range, 12 mo: −8.9 to −2.1 mm Hg • Net difference DBP, range, 12 mo: −4.4 to 0.0 mm Hg |
Fletcher et al,52 2015 | • d = 0.21 (95% CI 0.08–0.34) | • WMD SBP: −4.1 mm Hg, 95% CI −6.7 to −1.4 • WMD DBP: −2.0 mm Hg, 95% CI −2.9 to −1.1 |
Conn et al,11 2015 | • Self-monitoring (d = 0.381) vs no self-monitoring (d = 0.261) (P = .160) |
• Not assessed |
Conn et al,55 2016 | • Not assessed | • No difference in effect (effect sizes not reported) |
Abbreviations: CI, confidence interval; DBP, diastolic blood pressure; SBP, systolic blood pressure; WMD, weighted mean difference.